Workshop on Factors Limiting Progress in Blood Derived Pharmaceutical Development to be held September 11-13, 1987 at Lake Tahoe, California

关于限制血液衍生药物开发进展的因素研讨会将于 1987 年 9 月 11 日至 13 日在加利福尼亚州太浩湖举行

• 批准号: 8719880
• 负责人: C. Fred Fox
• 金额: $ 1.65万
• 依托单位: University of California-Los Angeles
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-09-01 至 1988-08-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=8719880&HistoricalAwards=false
• 关键词: Workshop; Factors; Limiting; Progress; Blood

Narrative: The recent emphasis on RDNA Technology has completely overshadowed efforts to recover naturally synthesized proteins that are present in trace amounts in blood plasma and are presently being discarded. This proposal intends to bring together experts from industry and academia to field important questions regarding the recovery of trace proteins via plasma fractionation. It is intended to assemble a complete list of protein candidates that have high potential for medical use. Also, to discuss the economics for recovery and whether or not RDNA Technology would be better suited for their manufacture. A final report will summarize the workshop and hopefully point the directions for funding basic and applied research in the field of plasma fractionation.

叙述：最近对 RDNA 技术的重视完全掩盖了回收自然合成蛋白质的努力，这些蛋白质在血浆中微量存在，目前正在被丢弃。 该提案旨在汇集工业界和学术界的专家，共同解决有关通过血浆分离回收微量蛋白质的重要​​问题。 它的目的是收集具有较高医疗用途潜力的候选蛋白质的完整列表。 此外，还讨论了回收的经济性以及 RDNA 技术是否更适合其制造。 最终报告将对研讨会进行总结，并希望为血浆分离领域的基础和应用研究提供资助指明方向。